Moexipril Hydrochloride 7.5 mg/1
Moexipril Hydrochloride · TABLET, FILM COATED · Teva Pharmaceuticals USA, Inc.
Moexipril Hydrochloride is a tablet, film coated containing moexipril hydrochloride at 7.5 mg/1, taken oral. Manufactured by Teva Pharmaceuticals USA, Inc..
Key Facts
- Brand Name
- Moexipril Hydrochloride
- Generic Name
- Moexipril Hydrochloride
- NDC Code (Product)
0093-0017- Manufacturer
- Teva Pharmaceuticals USA, Inc.
- Strength
- 7.5 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- ANDA076204
- Marketing Start
- 05/08/2003
Recall History
Teva Pharmaceuticals USA
Failed Impurities/Degradation Specifications: High out of specification test result for the Moexipril Diketopiperazine impurity was obtained during routine stability testing.
Side Effects Reported to FDA
FDA FAERS database · These are reported events, not confirmed side effects
Full Prescribing Information
Indications & Usage
INDICATIONS AND USAGE Moexipril hydrochloride tablets are indicated for treatment of patients with hypertension. It may be used alone or in combination with thiazide diuretics. In using moexipril hydrochloride tablets, consideration should be given to the fact that another ACE inhibitor, captopril, has caused agranulocytosis, particularly in patients with renal impairment or collagen-vascular disease. Available data are insufficient to show that moexipril hydrochloride tablets do not have a similar risk (see WARNINGS ). In considering use of moexipril hydrochloride tablets, it should be noted that in controlled trials ACE inhibitors have an effect on blood pressure that is less in black patients than in non-blacks. In addition, ACE inhibitors (for which adequate data are available) cause a higher rate of angioedema in black than in non-black patients (see WARNINGS, Angioedema ).
Dosage & Administration
DOSAGE AND ADMINISTRATION
Warnings
WARNINGS
Contraindications
CONTRAINDICATIONS Moexipril hydrochloride tablets are contraindicated in patients who are hypersensitive to this product and in patients with a history of angioedema related to previous treatment with an ACE inhibitor. Do not co-administer aliskiren with moexipril hydrochloride tablets in patients with diabetes (see PRECAUTIONS, Drug Interactions ).
Adverse Reactions
ADVERSE REACTIONS Moexipril hydrochloride tablets have been evaluated for safety in more than 2500 patients with hypertension; more than 250 of these patients were treated for approximately one year. The overall incidence of reported adverse events was only slightly greater in patients treated with moexipril hydrochloride tablets than patients treated with placebo. Reported adverse experiences were usually mild and transient, and there were no differences in adverse reaction rates related to gender, race, age, duration of therapy, or total daily dosage within the range of 3.75 mg to 60 mg. Discontinuation of therapy because of adverse experiences was required in 3.4% of patients treated with moexipril hydrochloride tablets and in 1.8% of patients treated with placebo. The most common reasons for discontinuation in patients treated with moexipril hydrochloride tablets were cough (0.7%) and dizziness (0.4%). All adverse experiences considered at least possibly related to treatment that occurred at any dose in placebo-controlled trials of once-daily dosing in more than 1% of patients treated with moexipril hydrochloride tablets alone and that were at least as frequent in the moexipril…
Frequently Asked Questions
What is Moexipril Hydrochloride used for?
Moexipril Hydrochloride contains Moexipril Hydrochloride. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Moexipril Hydrochloride a controlled substance?
Moexipril Hydrochloride is not classified as a controlled substance by the DEA.
What is the generic name for Moexipril Hydrochloride?
The generic name for Moexipril Hydrochloride is Moexipril Hydrochloride. There are no other listed brand versions of Moexipril Hydrochloride.
What is the NDC code for Moexipril Hydrochloride 7.5 mg/1?
The NDC (National Drug Code) for Moexipril Hydrochloride 7.5 mg/1 is 0093-0017, listed by Teva Pharmaceuticals USA, Inc..
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)